Crane NXT Co

After a strong Stage 2 advance with a new HH/HL sequence and a confirmed Devil’s Bargain continuation pattern, CXT remains tradable on the long side, but is currently extended above rising 9/21 EMAs and tagging overbought territory. Execution is best deferred until a pullback into the 9/21 EMA support zone, where acceptance into this zone would offer improved risk/reward participation aligned with the medium-term bullish bias.

• ↑Q1 revenue jumped 17% YoY to $388M with adjusted EPS up 11% to $0.60
• ↑Antares Vision integration underpins 15–17% 2026 sales growth guidance and $4.10–$4.40 EPS
• ↓Negative profitability metrics and margin pressure from rising operating costs